GlassScriptPhysician profile
Yashkumar Anilkumar Bhalala
NPI 1033802673
$6,426.96
in general payments reported to CMS, 2019-2025
25 companies · $3,887 in 2025
The $3,887 reported for 2025 was more than what 91% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $583 · 2024: $1,957 · 2025: $3,887.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,982 · Travel and Lodging: $1,445.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,981.85 |
| Travel and Lodging | $1,445.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $942.81 | 2025 | Motoband |
| Stryker Corporation | $918.90 | 2025 | Ortholoc 2 Lapifuse |
| Depuy Synthes Sales INC. | $632.05 | 2024-2025 | Motoband, Na, Motoband Cp |
| Integra Lifesciences Corporation | $517.85 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Bone Support INC. | $505.60 | 2024-2025 | Ceramentbone Void Filler, Cerament G |
| Acumed LLC | $489.76 | 2023-2025 | Acumed, Acumed, Osteomed |
| Paragon 28, INC. | $466.66 | 2023-2025 | Bun-Yo-Matic, Portfolio, Monkey Bars |
| Kerecis Limited | $408.29 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Pinnacle, INC | $295.51 | 2023-2025 | |
| Kuros Biosciences USA, INC | $223.73 | 2024-2025 | Magnetos |
| Solventum Corporation | $213.67 | 2024-2025 | Prevena, V.A.C.Ulta, V.A.C. Veraflo |
| Orthofix Medical, INC. | $133.40 | 2024-2025 | Physio-Stim, Cervical-Stim, Spinal-Stim |
| Davol INC. | $124.71 | 2025 | Surgiphor, Arista |
| Exactech, INC. | $113.97 | 2025 | |
| Medtronic, INC. | $110.59 | 2024 | Venaseal |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Averitas Pharma INC. | $80.54 | 2023-2025 | Qutenza |
| Restor3d, INC. | $67.48 | 2024 | |
| Surgenex LLC | $36.26 | 2025 | Surmatrix, Pellograft, Surgraft |
| Lifenet Health | $24.38 | 2024 | Theragenesis Wound Matrix |
| Aroa Biosurgery Incorporated | $24.25 | 2024 | |
| Heron Therapeutics, INC. | $23.55 | 2025 | Zynrelef |
| Paratek Pharmaceuticals, INC. | $21.92 | 2024 | Nuzyra |
| Smith+Nephew, INC. | $18.49 | 2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Amgen INC. | $17.79 | 2025 | Krystexxa |
| Bioventus LLC | $14.80 | 2024 | Exogen Ultrasound Bone Healing System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yashkumar Anilkumar Bhalala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.